George B. Abercrombie
Director, INSPIRE PHARMACEUTICALS INC.
Companies
- BioCryst PharmaceuticalsBoard member Oct 11, 2011 to Jun 14, 20241
- Fresh Tracks Therapeutics, Inc.Chief executive officer Feb 19, 2020 to Feb 19, 20202
- Fresh Tracks Therapeutics, Inc.Board member Sep 9, 2019 to Feb 19, 20203
- Innoviva, Inc.Sr. VP, Corp. Partnerships Jun 12, 2014 to Aug 22, 20184
- ZIOPHARM OncologyBoard member Apr 6, 2010 to Apr 6, 20105
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
BioCryst Pharmaceuticals BCRX36,431 shares6$290.9K at $7.99Jun 12, 2024
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 12, 2024Granted 6,820 shares of BioCryst Pharmaceuticals6
- Jun 13, 2023Granted 16,745 shares of BioCryst Pharmaceuticals7
- Jun 7, 2022Granted 12,866 shares of BioCryst Pharmaceuticals8
- Apr 18, 2022Sold 5,000 shares at $11.04 of BioCryst Pharmaceuticals9
- Apr 18, 2022Exercised options 5,000 shares at $3.32 of BioCryst Pharmaceuticals9
- Feb 15, 2022Sold 5,000 shares at $18.50 of BioCryst Pharmaceuticals10
- Feb 15, 2022Exercised options 5,000 shares at $3.32 of BioCryst Pharmaceuticals10
- Nov 15, 2021Sold 5,000 shares at $12.27 of BioCryst Pharmaceuticals11
- Nov 15, 2021Exercised options 5,000 shares at $3.32 of BioCryst Pharmaceuticals11
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5SEC EDGARZIOPHARM Oncology, Board member
- 6
- 7SEC EDGARForm 4 filed Jun 15, 2023
- 8SEC EDGARForm 4 filed Jun 9, 2022
- 9SEC EDGARForm 4 filed Apr 20, 2022
- 10SEC EDGARForm 4 filed Feb 16, 2022
- 11SEC EDGARForm 4 filed Nov 17, 2021